A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients-Reference-Cited by-同舟云学术

A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients

Published:2016-03-14 Issue:5 Volume:30 Page:528-533
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Fleming James N.¹,Taber David J.²³,Pilch Nicole A.¹,McGillicuddy John W.²,Srinivas Titte R.⁴,Baliga Prabhakar K.²,Chavin Kenneth D.²,Bratton Charles F.²

Affiliation:

1. Department of Pharmacy Services; Medical University of South Carolina; Charleston SC USA

2. Department of Surgery; Medical University of South Carolina; Charleston SC USA

3. Department of Pharmacy; Ralph H Johnson VAMC; Charleston SC USA

4. Department of Nephrology; Medical University of South Carolina; Charleston SC USA

Funder

Pfizer

Publisher

Wiley

Subject

Transplantation

Reference20 articles.

1. Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation;Lo;Transplantation,2004

2. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years;Flechner;Am J Transplant,2004

3. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs;Flechner;Transplantation,2007

4. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year;Mendez;Transplantation,2005

5. Reduced exposure to calcineurin inhibitors in renal transplantation;Ekberg;N Engl J Med,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prospect for the diagnostic management team to streamline virtual and physical crossmatching;Transplant Immunology;2022-08

2. A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients;Chinese Medical Journal;2022-07-05

3. Improving Access to HLA-Matched Kidney Transplants for African American Patients;Frontiers in Immunology;2022-03-24

4. Calcineurin Inhibitors Nephrotoxicity Prevention Strategies With Stress on Belatacept-Based Rescue Immunotherapy: A Review of the Current Evidence;Transplantation Proceedings;2021-06

5. Metabolic and Renal Effects of Mammalian Target of Rapamycin Inhibitors Treatment After Liver Transplantation: Real-Life Single-Center Experience;Transplantation Proceedings;2021-01